Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils
- PMID: 12920210
- DOI: 10.1124/mol.64.3.721
Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils
Abstract
Classical chemoattractant receptors are of fundamental importance to immune responses. The two major roles of such receptors are the modulation of chemotaxis and the generation of reactive oxygen species. The formyl peptide receptor-like 1 (FPRL1) can be stimulated by two different ligands, Trp-Lys-Tyr-Met-Val-Met-CONH2 (WKYMVM) and lipoxin A4 (LXA4). Although leukocyte chemotaxis mediated by activated FPRL1 has been reported, the role of FPRL1 in superoxide generation remains to be studied. In this study, we examined the effect of WKYMVM or LXA4 on chemotactic migration and superoxide generation in human neutrophils. WKYMVM and LXA4 stimulated neutrophil chemotaxis via tyrosine phosphorylation events. In terms of reactive oxygen species generation, WKYMVM but not LXA4 stimulated superoxide generation in neutrophils. To understand this difference on superoxide generation via the same receptor, FPRL1, we compared the signaling pathways downstream of FPRL1 by the two different ligands. At first, we confirmed that both WKYMVM and LXA4 caused intracellular calcium ([Ca2+]i) increase in a pertussis toxin-sensitive manner and that these ligands competitively inhibited each other with respect to [Ca2+]i increase in neutrophils. This result suggests that WKYMVM and LXA4 share the same receptor, FPRL1. By investigating cellular signaling by WKYMVM and LXA4, we found that WKYMVM but not LXA4 induced extracellular signal-regulated protein kinases (ERKs), c-Jun NH2-terminal kinase, and phospholipase A2 (PLA2) activation. We also found that ERK-mediated cytosolic PLA2 activity is essential for superoxide generation. These results indicate that the activation of FPRL1 by the two different ligands can induce differential cellular signaling and unique functional consequences in human neutrophils.
Similar articles
-
The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.Biochem Pharmacol. 2007 Oct 1;74(7):1050-6. doi: 10.1016/j.bcp.2007.06.049. Epub 2007 Jul 7. Biochem Pharmacol. 2007. PMID: 17692291
-
Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.J Immunol. 1999 Dec 15;163(12):6777-84. J Immunol. 1999. PMID: 10586077
-
Differential activation of formyl peptide receptor signaling by peptide ligands.Mol Pharmacol. 2003 Oct;64(4):841-7. doi: 10.1124/mol.64.4.841. Mol Pharmacol. 2003. PMID: 14500740
-
A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.Forum (Genova). 1999 Oct-Dec;9(4):299-314. Forum (Genova). 1999. PMID: 10611407 Review.
-
Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils.Eur J Pharmacol. 2006 Mar 18;534(1-3):1-11. doi: 10.1016/j.ejphar.2006.01.034. Epub 2006 Mar 3. Eur J Pharmacol. 2006. PMID: 16516193 Review.
Cited by
-
Release of immunomodulatory peptides at bacterial membrane interfaces as a novel strategy to fight microorganisms.J Biol Chem. 2023 Apr;299(4):103056. doi: 10.1016/j.jbc.2023.103056. Epub 2023 Feb 22. J Biol Chem. 2023. PMID: 36822328 Free PMC article.
-
A signaling network map of Lipoxin (LXA4): an anti-inflammatory molecule.Inflamm Res. 2024 Jul;73(7):1099-1106. doi: 10.1007/s00011-024-01885-6. Epub 2024 Apr 26. Inflamm Res. 2024. PMID: 38668877 Review.
-
Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.Mol Pharmacol. 2011 Jan;79(1):77-90. doi: 10.1124/mol.110.068288. Epub 2010 Oct 13. Mol Pharmacol. 2011. PMID: 20943772 Free PMC article.
-
Formyl Peptide Receptor 2-Dependent cPLA2 and 5-LOX Activation Requires a Functional NADPH Oxidase.Antioxidants (Basel). 2024 Feb 8;13(2):220. doi: 10.3390/antiox13020220. Antioxidants (Basel). 2024. PMID: 38397818 Free PMC article.
-
Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.Br J Pharmacol. 2022 Oct;179(19):4617-4639. doi: 10.1111/bph.15919. Epub 2022 Jul 29. Br J Pharmacol. 2022. PMID: 35797341 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous